Amgen AMGN
NASDAQ AMGN
$433.73 -8.63 (-1.95%)
At close: Aug 20, 2026 · 4:00 PM EDT

Amgen (AMGN) EBITDA Margin (2009 - 2026)

Amgen (AMGN) posted quarterly EBITDA Margin of 30.94% for Q1 2026, up 1648.0% year-over-year from 1.77% in Q1 2025, and up 12.21% quarter-over-quarter from 27.57% in Q4 2025.

Amgen (AMGN) EBITDA Margin (2009 - 2026) Analysis & Trends

Amgen's EBITDA Margin history runs 18 years deep, the most recent figure standing at 30.94% for Q1 2026.

  • In Q1 2026, EBITDA Margin rose 1648.0% year-over-year to 30.94%; the TTM figure through Mar 2026 stood at 28.39% (up 658.0% YoY), while the FY2025 annual figure was 24.71%, up 299.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 30.94%, up from 27.57% in the prior quarter.
  • The five-year high for EBITDA Margin was 485.84% in Q4 2022, with the low at 13.31% in Q1 2024.
  • The 5-year median for EBITDA Margin is 28.94% (2025), against an average of 54.56%.
  • The sharpest annual moves came in 2022 and 2023: EBITDA Margin jumped 45218 bps in 2022, then tumbled 47033 bps in 2023.
  • Amgen's EBITDA Margin stood at 485.84% in 2022, then tumbled by 97 bps to 15.51% in 2023, then jumped by 64 bps to 25.43% in 2024, then climbed by 8 bps to 27.57% in 2025, then advanced by 12 bps to 30.94% in 2026.
  • Business Quant data shows AMGN's EBITDA Margin at 30.94% in Q1 2026, 27.57% in Q4 2025, and 26.43% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn 28.21%
2 AbbVie 463.46 Bn 456.89 Bn 12.70 Bn 37.86%
3 Merck 367.92 Bn 360.78 Bn 12.21 Bn -3.52%
4 Novartis Ag 297.71 Bn 290.02 Bn 11.24 Bn 32.97%
5 Astrazeneca 255.55 Bn 250.65 Bn 12.86 Bn 20.57%
6 Amgen 234.52 Bn 220.53 Bn 7.24 Bn 34.95%
7 Gilead Sciences 178.22 Bn 175.04 Bn 6.22 Bn -133.21%
8 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 28.37%
9 Gsk 105.32 Bn 101.15 Bn 8.24 Bn 5.72%
10 Sanofi 54.20 Bn 46.82 Bn 10.79 Bn 124.39%

Historic Data

Download Data
DateValue
Jun 30, 2026 34.95%
Mar 31, 2026 30.94%
Dec 31, 2025 27.57%
Sep 30, 2025 26.43%
Jun 30, 2025 28.94%
Mar 31, 2025 14.46%
Dec 31, 2024 25.43%
Sep 30, 2024 24.07%
Jun 30, 2024 22.76%
Mar 31, 2024 13.31%
Dec 31, 2023 15.51%
Sep 30, 2023 29.28%
Jun 30, 2023 38.42%
Mar 31, 2023 31.47%
Dec 31, 2022 485.84%
Sep 30, 2022 39.99%
Jun 30, 2022 33.00%
Mar 31, 2022 40.08%
Dec 31, 2021 33.65%
Sep 30, 2021 35.46%